Position in NVO
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$47,972,695
+$9,288,837 QoQ
Shares Held
1,000,682
-4.9% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#57
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $392,709,829 across 14 Drug Manufacturers - General names. NVO ranks #4 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
74,694 | $89,590,231 | |
| 2 | JNJ |
Johnson & Johnson
|
345,519 | $87,751,460 | |
| 3 | ABBV |
AbbVie Inc.
|
254,843 | $64,128,692 | |
| 4 | NVO |
Novo Nordisk A S
This page
|
1,000,682 | $47,972,695 | |
| 5 | AMGN |
Amgen Inc
|
90,846 | $32,897,153 | |
| 6 | MRK |
Merck & Co., Inc.
|
142,059 | $18,254,581 | |
| 7 | NVS |
Novartis AG
|
89,770 | $14,068,754 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
108,152 | $13,663,923 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,972,695 | 1,000,682 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $38,683,858 | 1,052,622 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $32,988,200 | 648,353 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $35,391,910 | 637,807 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $38,140,521 | 552,601 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $40,017,438 | 576,288 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $30,984,834 | 360,205 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $50,113,824 | 420,877 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $63,371,849 | 443,967 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $61,776,064 | 481,122 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $56,122,762 | 542,511 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $87,446,812 | 961,588 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $90,882,757 | 561,594 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $94,647,560 | 594,744 | Shares | Defined | 2023-08-15 | |
| 2022-12-31 | $84,946,015 | 627,649 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $65,711,165 | 659,552 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $77,070,559 | 691,650 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $84,877,180 | 764,315 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $90,027,392 | 803,816 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $78,746,633 | 820,192 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $71,043,661 | 848,080 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $55,704,224 | 826,227 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $58,841,151 | 842,393 | Shares | Defined | 2021-02-17 | |
| 2020-09-30 | $58,993,560 | 849,684 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $59,712,128 | 911,914 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $51,381,723 | 853,517 | Shares | Defined | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||